Literature DB >> 34253930

A French cohort for assessing COVID-19 vaccine responses in specific populations.

Paul Loubet1,2, Linda Wittkop3,4, Eric Tartour5, Beatrice Parfait6, Benoit Barrou7, Jean-Yves Blay8, Maryvonne Hourmant9, Marie Lachâtre10,11, David-Axel Laplaud12, Martine Laville13, Bruno Laviolle14, Jean-Daniel Lelievre15, Jacques Morel16, Stéphanie Nguyen17, Jean-Philippe Spano18, Benjamin Terrier19, Anne Thiebaut20, Jean-Francois Viallard21, François Vrtovsnik22, Xavier de Lamballerie23, Odile Launay10,24.   

Abstract

Entities:  

Year:  2021        PMID： 34253930     DOI： 10.1038/s41591-021-01435-1

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  5 in total

Review 1.  Seroconversion rate after vaccination against COVID-19 in patients with cancer-a systematic review.

Authors:  C Corti; G Antonarelli; F Scotté; J P Spano; J Barrière; J M Michot; F André; G Curigliano
Journal:  Ann Oncol       Date:  2021-10-28       Impact factor: 32.976

2.  Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis.

Authors:  Andrea Becerril-Gaitan; Bryan F Vaca-Cartagena; Ana S Ferrigno; Fernanda Mesa-Chavez; Tonatiuh Barrientos-Gutiérrez; Marco Tagliamento; Matteo Lambertini; Cynthia Villarreal-Garza
Journal:  Eur J Cancer       Date:  2021-10-26       Impact factor: 9.162

Review 3.  Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article.

Authors:  Jérôme Barrière; Michel Carles; Clarisse Audigier-Valette; Daniel Re; Zoubir Adjtoutah; Barbara Seitz-Polski; Valérie Gounant; Diane Descamps; Gérard Zalcman
Journal:  Eur J Cancer       Date:  2021-12-16       Impact factor: 9.162

4.  One-month humoral response following two or three doses of mRNA Covid-19 vaccines as primary vaccination in specific populations in France: first results from the ANRS0001S COV-POPART cohort.

Authors:  Paul Loubet; Linda Wittkop; Laetitia Ninove; Mathieu Chalouni; Benoit Barrou; Jean-Yves Blay; Maryvonne Hourmant; Eric Thouvenot; Martine Laville; Bruno Laviolle; Jean-Daniel Lelievre; Jacques Morel; Stéphanie Nguyen Quoc; Jean-Philippe Spano; Benjamin Terrier; Anne Thiebaut; Jean-Francois Viallard; François Vrtovsnik; Sophie Circosta; Laure Esterle; Axel Levier; Philippe Vanhems; Eric Tartour; Beatrice Parfait; Xavier de Lamballerie; Odile Launay
Journal:  Clin Microbiol Infect       Date:  2022-10-14       Impact factor: 13.310

5.  Graves' disease following vaccination against SARS-CoV-2: A systematic review of the reported cases.

Authors:  Konstantinos Katsikas Triantafyllidis; Panagiotis Giannos; Dimitra Stathi; Konstantinos S Kechagias
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.